Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:429 (1 September), doi:10.1136/bmj.39274.647465.BE (published 26 July 2007)
Angela Chung, clinical research fellow1, Rafael Perera, senior research fellow in statistics1, Angela B Brueggemann, infectious disease lecturer2, Abdel E Elamin, research student3, Anthony Harnden, university lecturer1, Richard Mayon-White, consultant epidemiologist1, Susan Smith, research group coordinator1, Derrick W Crook, consultant in infectious disease and microbiology3, David Mant, professor1
1 Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, Oxford OX3 7LF, 2 Department of Zoology, University of Oxford, Oxford OX1 3PS, 3 Nuffield Department of Clinical and Laboratory Science, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU
Correspondence to: D Mant david.mant{at}dphpc.ox.ac.uk
Study design Observational cohort study with follow-up at two and 12 weeks.
Setting General practices in Oxfordshire.
Participants 119 children with acute respiratory tract infection, of whom 71 received a
lactam antibiotic.
Main outcome measures Antibiotic resistance was assessed by the geometric mean minimum inhibitory concentration (MIC) for ampicillin and presence of the ICEHin1056 resistance element in up to four isolates of Haemophilus species recovered from throat swabs at recruitment, two weeks, and 12 weeks.
Results Prescribing amoxicillin to a child in general practice more than triples the mean minimum inhibitory concentration for ampicillin (9.2 µg/ml v 2.7 µg/ml, P=0.005) and doubles the risk of isolation of Haemophilus isolates possessing homologues of ICEHin1056 (67% v 36%; relative risk 1.9, 95% confidence interval 1.2 to 2.9) two weeks later. Although this increase is transient (by 12 weeks ampicillin resistance had fallen close to baseline), it is in the context of recovery of the element from 35% of children with Haemophilus isolates at recruitment and from 83% (76% to 89%) at some point in the study.
Conclusion The short term effect of amoxicillin prescribed in primary care is transitory in the individual child but sufficient to sustain a high level of antibiotic resistance in the population.
Although a strong correlation between antibiotic prescribing and resistance might seem inevitable from a Darwinian perspective, the relation is complex.4 Actual resistance levels will depend on the pattern of antibiotic use, the specific interaction between bacterium and drug, the potential for transmission, and the stage the country is at in the evolution of resistance. For example, Sweden and Denmark have higher rates of penicillin prescribing than the UK but lower resistance, while Finland has lower prescribing but higher resistance.1 Similarly, community studies from Iceland have shown that the association between a reduction in prescribing and resistance is not straightforward.5 6 To develop an effective strategy to manage antibiotic resistance in the community we need to understand what is happening at the level of the individual patient, not just to inform care of patients but also to provide firm estimates for the population models that should inform policy on antibiotic prescribing.
The highest rates of antibiotic prescribing in primary care are to children with respiratory illness but surprisingly there have been few prospective controlled studies of the impact of such prescribing on resistance in a community setting. In the 1980s Brook reported isolation of
lactam producing bacteria in 46% of children one week after antibiotic treatment of otitis media or pharyngitis and 27% after three months compared with a constant 11% in controls.7 A paper from Malawi in 2000 reported recovery of co-trimoxazole resistant pneumococci in 52% of children one week after malaria treatment with co-trimoxazole compared with 34% in controls but with no difference after four weeks.8 An Australian study in 2002 reported a twofold increase in the odds of recovery of resistant pneumococci in children who had used
lactam antibiotics in the two months before swab collection.9 We report a prospective study in children from UK general practice with new methods for identifying a highly mobile integrative and conjugative element (ICE) that encodes
lactamase and circulates among nasopharyngeal Haemophilus species.10 11 12
lactam antibiotic (amoxicillin 70, cephradine 1) at presentation and 48 received no antibiotic.
Data collection and follow-up
A research nurse collected information on sociodemographic details, type of infection, child's past antibiotic use, and treatment for current illness as well as obtaining ethical consent from the parent. Information on antibiotic prescribing was confirmed from the medical records. Children were followed up on two occasions, at two weeks and 12 weeks after recruitment.
Microbiology
A trained research nurse took throat swabs. Each cotton tipped wooden swab was transported in enriched tryptic soy broth. The samples were vortexed and the broth stored at –80°C for batch processing. At the time of processing, 50 µl samples were inoculated onto two Haemophilus selective media: Columbia agar (enriched with haemin and nicotinamide adenine dinucleotide) plus bacitracin, and the same agar with the addition of 2 µg/ml ampicillin. Plates were incubated at 37°C plus 5% CO2 for 48 hours. Up to four morphologically different colonies were picked from the bacitracin plate and two morphologically different colonies from the ampicillin plate. The colonies were purified by subculturing on to chocolate agar. Assessment of ampicillin minimum inhibitory concentration level (Etest, AB Biodisk, Solna, Sweden) was performed in accordance with US National Committee of Clinical and Laboratory Standards guidelines. The presence of the integrative and conjugative element homologous to ICEHin1056 was performed following a method previously described13 with a multiplex assay targeting regions of the topoisomerase gene and orf 51 (as annotated in the complete sequence of ICEHin1056; accession number AJ627386, table 1).
|
Analysis
Analysis of data was performed with SPSS for Windows (version 12.0). We used the
2 test to compare categorical data between groups at each visit. As the minimum inhibitory concentration for ampicillin is highly skewed we applied a log transformation to this measurement and used geometric means to summarise this measure. We used t tests to compare the means between groups at each visit and paired t tests to compare the means within groups. Where data are reported in relation to individual children rather than individual isolates, the denominator is limited to children in whom Haemophilus species were isolated (because antibiotic resistance is a characteristic of the colonising bacterium, not of the child). As we recovered Haemophilus species from nearly all children, however, the results would be similar if we included all children in the denominator.
Initial differences between children
Table 2 provides data on children according to whether they were prescribed an antibiotic.
Mean age (both 5.4 years), mean number of children in household (1.16 v 1.13), and previous exposure to antibiotics (87% v 85%) were similar. Day care or school attendance was more common in the children who received an antibiotic (66/69 (95%) v 40/47 (85%), P=0.05). The geometric mean of the minimum inhibitory concentration for ampicillin of the Haemophilus species isolates was 2.4 µg/ml in the antibiotic group and 4.1 µg/ml in the no antibiotic group (P=0.24). The proportion of children with an isolate carrying an integrative and conjugative element was 32% and 38%, respectively (P=0.52). Carriage of the element was common even in children who had never received an antibiotic (8/15, 53%).
|
|
|
The integrative and conjugative element can be isolated from both pathogenic H influenzae and commensal H parainfluenzae and like a plasmid moves freely between them by horizontal transfer.12 13 14 It is this global gene pool of transferable antibiotic resistance elements that maintains antibiotic resistance in the community. We recognise that other potential respiratory tract pathogens accrue resistance (including penicillin resistance in pneumococci and methicillin resistance in staphylococci) by mutation of chromosomal genes rather than conjugative mechanisms and therefore we cannot necessarily generalise our results to those species. Our results, however, are consistent with the report by Nasrin et al of a doubling of odds of isolation of penicillin resistant pneumococci from children who had received a
lactam antibiotic within two months but not six months.9
Prescribing antibiotics to children remains common practice. A paper published in 1999 reported that 55% of children aged 0-5 years in the UK (the group of patients who receive most antibiotics in the community) receive an average of 2.2 prescriptions for a
lactam antibiotic from their general practitioner each year.15 Although a reduction in prescribing (and the strategy of recommending a 24-48 hour delay before filling antibiotic prescriptions) has probably resulted in about a 40% fall in consumption since then,16 unpublished data reported to the paediatric subgroup of the standing advisory committee on antibiotic resistance suggest that community antibiotic prescribing is again rising.
Using our results to estimate the effect of this prescribing on resistance is not straightforward. If our ability to recover an integrative and conjugative element mirrors the change in transmission potential, the marginal effect of community prescribing on the proportion of children in the UK who are able to transmit an integrative and conjugative element at any one time is perhaps 2-3%. However, this does not imply a marginal 2-3% impact on resistance because this is not a static system. For example, applying a transmission dynamics model to data from Finland, Austin et al showed that a paediatric prescribing rate of 14 days of antibiotics each year, and an estimated duration of carriage of a
lactamase producing strain of Moraxella catarrhalis of just over one month, was consistent with an increase in community prevalence of these strains by about 10% a year to an equilibrium level of about 50%.17 These parameter estimates are not dissimilar in magnitude to the prescribing rates cited above and the duration of increased recovery of the integrative and conjugative element we observed.
Clinical implications
In the few cases where it is appropriate to repeat the prescription of an antibiotic within under three months, it may be sensible to choose one (for example, co-amoxiclav) that has activity against
lactamase producing strains, rather than give a further course of amoxicillin. From a population perspective, the issue of concern is the high (about 35%) equilibrium level of recovery of resistant Haemophilus species to which the children receiving antibiotics returned after 12 weeks and the endemic carriage of the integrative and conjugative element by nasopharyngeal Haemophilus species. This may indicate that bacteria can adapt to carry the resistance element with minimal metabolic cost and therefore without much biological disadvantage in the absence of antibiotic selection. In this situation, the model proposed by Austin et al further predicts that any reduction in community resistance is likely to need a substantial and sustained reduction in community prescribing.17 One option that deserves further investigation, and is supported by Nasrin's data,9 is to reduce the duration of each course of antibiotics prescribed in the community. A more radical option is to advise stopping prescribing antibiotics to any child with respiratory infection in the community except in well defined and exceptional circumstances. Although such a strategy may be easier to implement than a discretionary policy based on the difficult, and perhaps impossible, clinical discrimination between viral and bacterial infection, it does run the risk of some children with bacterial disease being treated later in the course of their illness.
|
Funding: Medical Research Council. Oxford University department of primary health care also receives programme funding for this area of research as part of the NIHR National School of Primary Care Research.
Competing interests: None declared.
Ethical approval: Central Oxford NHS research ethics committee.
Provenance and peer review: Non-commissioned, externally peer reviewed.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses